[1] Cheng EY.Surgical management of sarcomas[J].Hematol Oncol Clin North Am,2005,19(3):451-470.DOI:10.1016/j.hoc.2005.03.009.
[2] Perez和Brady.放射肿瘤学原理和实践[M].5版.朱广迎,李晔雄,夏廷毅等,译.天津:天津科技翻译出版公司,2012:2000-2003.
[3] Kaytan E,Yaman F,Cosar R,et al.Prognostic factors in localized soft-tissue sarcomas[J].Am J Clin Oncol,2003,26(4):411-415.
[4] Kim YB,Shin KH,Seong J,et al.Clinical significance of margin status in postoperative radiotherapy for extremity and truncal soft-tissue sarcoma[J].Int J Radial Oncol Biol Phys,2008,70(1):139-144.DOI:10.1016/j.ijrobp.2007.05.067.
[5] Casali PG,Blay JY.Soft tissue sarcomas:ESMO clinical practice guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2010,21(Suppl 5):v198-v203.DOI:10.1093/annonc/mdq209.
[6] Grimer R,Judson I,Peake D,et al.Guidelines for the management of soft tissue sarcomas[J/OL].Sarcoma,2010,2010:506182[2014-05-28].DOI:10.1155/2010/506182.
[7] Mocellin S,Rossi CR,Brabdes A,et al.Adult soft tissue sarcomas:conventional therapies and molecularly targeted approaches[J].Cancer Treat Rev,2006,32(1):9-27.DOI:10.1016/j.ctrv.2005.10.003.
[8] Mierzwa ML,McCluskey CM,Barrett WL,et al.Interstitial brachytherapy for soft tissue sarcoma:a single institution experience[J].Brachytherapy,2007,6(4):298-303.DOI:10.1016/j.brachy.2007.08.004.
[9] 李涛,陶惠民,胡福军,等.术中置管联合高剂量率近距离放疗治疗11例软组织肉瘤[J].中国肿瘤临床,2007,34(13):767-769.DOI:10.3969/j.issn.1000-8179.2007.13.014. |
|
|
2015, Vol. 24 
